Five Year Low in Cash Flow from Operations for Halozyme Therapeutics
Stock Quote:(NGM:HALO)
11/17/2009
7.17
+0.16
+2.28%
391,706
Five Year Low in Cash Flow from Operations for Halozyme Therapeutics
Last
Price Change
% Chg
Volume
New York, NY, November 17, 2009-CFFO-NEWS reports that negative Cash Flow from Operations (CFFO) for Halozyme Therapeutics, Inc. (NASDAQ:HALO) for its quarter ended September 30, 2009 was $(14,482,926 ... read full story
Stocks ended flat and closed July with the strongest monthly gains in a year. The markets were volatile throughout the session following mixed economic data earlier. Recovery concerns were renewed after GDP growth slowed in Q2, but Chicago PMI jumped ... read full story